Syntara (ASX:SNT) Days Payable: 0.00 (As of Dec. 2025)


What is Syntara Days Payable?

Syntara ASX:SNT +5.26% Days Payable is 0.00 as of Dec. 2025. The stock has 1 warning sign investors should review. Among 920 Drug Manufacturers companies, Syntara ranks worse than 108695.54% on this metric.

Syntara's average Accounts Payable for the six months ended in Dec. 2025 was A$2.71 Mil. Syntara's Cost of Goods Sold for the six months ended in Dec. 2025 was A$0.00 Mil.

The historical rank and industry rank for Syntara's Days Payable or its related term are showing as below:

During the past 13 years, Syntara's highest Days Payable was 148.17. The lowest was 148.17. And the median was 148.17.

ASX:SNT's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.835
* Ranked among companies with meaningful Days Payable only.

Syntara's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).

Syntara Days Payable Historical Data

* Premium members only.

The historical data trend for Syntara's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syntara Days Payable Chart

Syntara Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 148.17 0.00 0.00

Syntara Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASX:SNT vs ZTS, UTHR: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Syntara's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syntara Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syntara's Days Payable distribution charts can be found below:

* The bar in red indicates where Syntara's Days Payable falls into.


Syntara Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Syntara's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as

Days Payable (A: Jun. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jun. 2024 ) + Accounts Payable (A: Jun. 2025 )) / count ) / Cost of Goods Sold (A: Jun. 2025 )*Days in Period
=( (0.614 + 2.517) / 2 ) / 0*365
=1.5655 / 0*365
=N/A

Syntara's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (2.517 + 2.899) / 2 ) / 0*365 / 2
=2.708 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Syntara (ASX:SNT) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Syntara and its competitors. Over the past decade, Syntara's Days Payable has ranged from 148.17 to 148.17. According to the industry distribution chart, Syntara ranks #999999 out of 920 companies in the Drug Manufacturers industry.
Is Syntara's Days Payable too high?
Syntara's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 148.17 to a high of 148.17. Based on the distribution chart, Syntara ranks #999999 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Syntara's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Syntara ranks #999999 out of 920 companies for Days Payable. This places Syntara in the lower half of its industry. The industry median Days Payable is 90.84. Historically, Syntara's own Days Payable has ranged from 148.17 to 148.17 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Syntara and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syntara's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syntara stock overvalued right now?
Syntara (ASX:SNT) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Syntara (ASX:SNT), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syntara Business Description

Other Exchanges UUDA:Germany
Address 20 Rodborough Road, Unit 2, Frenchs Forest, Sydney, NSW, AUS, 2086
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring and neuroinflammation.